Guyer William Insider Trades

Insider Trading History

Track insider trading activity for Guyer William. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Development Officer
Holding Value $1.62M 22,231 shares
Last Trade
May 05, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.03M 20,000 shares
$51.33
$72.65
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Development Officer
Holding Value $12.4M 170,000 shares
Last Trade
May 05, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.03M 20,000 shares
$51.33
$72.65
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Development Officer
Holding Value $162k 2,231 shares
Last Trade
May 05, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.04M 20,000 shares
$51.83
$72.65
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Development Officer
Holding Value $1.62M 22,231 shares
Last Trade
Apr 07, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$834k 20,000 shares
$41.69
$72.65
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Development Officer
Holding Value $13.8M 190,000 shares
Last Trade
Apr 07, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$834k 20,000 shares
$41.69
$72.65
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Development Officer
Holding Value $162k 2,231 shares
Last Trade
Apr 07, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$819k 20,000 shares
$40.97
$72.65
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Development Officer
Holding Value $162k 2,231 shares
Last Trade
Mar 20, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$424k 11,767 shares
$36.01
$72.65
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Development Officer
Holding Value $15.3M 210,000 shares
Last Trade
Mar 20, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$408k 11,767 shares
$34.64
$72.65
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Development Officer
Holding Value $1.02M 13,998 shares
Last Trade
Mar 20, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$408k 11,767 shares
$34.64
$72.65
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Development Officer
Holding Value $162k 2,231 shares
Last Trade
Mar 04, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$296k 8,233 shares
$35.99
$72.65
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Development Officer
Holding Value $16.1M 221,767 shares
Last Trade
Mar 04, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$294k 8,233 shares
$35.69
$72.65
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Development Officer
Holding Value $760k 10,464 shares
Last Trade
Mar 04, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$294k 8,233 shares
$35.69
$72.65
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Development Officer
Holding Value $162k 2,231 shares
Last Trade
Mar 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$35.8k 996 shares
$35.97
$72.65
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Development Officer
Holding Value $10.2M 140,000 shares
Last Trade
Feb 27, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5M 140,000 shares
$35.70
$72.65
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Development Officer
Holding Value $16.7M 230,000 shares
Last Trade
Feb 03, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$814k 20,000 shares
$40.71
$72.65
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Development Officer
Holding Value $89.7k 1,235 shares
Last Trade
Feb 03, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$817k 20,000 shares
$40.87
$72.65
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Development Officer
Holding Value $1.54M 21,235 shares
Last Trade
Feb 03, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$814k 20,000 shares
$40.71
$72.65
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Development Officer
Holding Value $89.7k 1,235 shares
Last Trade
Jan 06, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$704k 20,000 shares
$35.18
$72.65
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Development Officer
Holding Value $1.54M 21,235 shares
Last Trade
Jan 06, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$716k 20,000 shares
$35.78
$72.65
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Development Officer
Holding Value $18.2M 250,000 shares
Last Trade
Jan 06, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$716k 20,000 shares
$35.78
$72.65

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up